Intervention

Hydrochlorothiazide (HCTZ)

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting0

Common conditions10

Lead sponsors shown7

Clinical trials

12 shown

Diuretic Comparison ProjectNCT02185417 · 2016-06-15

A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)NCT01370655 · 2011-06-15

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly PeopleNCT01259297 · 2011-01-01

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential HypertensionNCT01256411 · 2010-11-01

ALiskiren or Losartan Effects on bioMARKers of Myocardial RemodelingNCT01176032 · 2010-06-01

Aldosterone and the Metabolic SyndromeNCT01103245 · 2010-03-01

Salt Loading and Thiazide Intervention StudyNCT00896389 · 2009-10-01

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)NCT00871871 · 2009-03-01

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes MellitusNCT00787605 · 2008-11-01

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe HypertensionNCT00765674 · 2008-09-01

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideNCT00671424 · 2008-03-01

A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.NCT00386607 · 2006-10-01

Common conditions

Hypertension8 Diabetes Mellitus2 Cardiovascular Events1 Diabetes Mellitus, Type 21 Endocrine System Diseases1 Essential Hypertension1 Glucose Metabolism Disorders1 Left Ventricle Hypertrophy1 Metabolic Diseases1 Type 2 Diabetes Mellitus1

Leading sponsors

Novartis3 Novartis Pharmaceuticals3 Merck Sharp & Dohme LLC2 GlaxoSmithKline1 University of Maryland, Baltimore1 VA Office of Research and Development1 Vanderbilt University Medical Center1

Trial status mix

COMPLETED11

TERMINATED1

Phase mix

PHASE14

PHASE34

PHASE43

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.